TB-500 Frag

TB-500 Frag (Fragment) 10 mg



TB-500 Frag is an investigational peptide fragment derived from Thymosin Beta-4 (TB-500). It is being studied for its potential to support tissue repair, muscle recovery, and regenerative processes while retaining selected biological activities of the parent peptide. Research on the fragment is more limited than research on full-length Thymosin Beta-4.



Potential Benefits



Muscle Recovery



* Supports recovery after intense physical activity

* May help reduce muscle soreness

* Promotes healthy muscle function

* Supports rehabilitation following injury



Tendon & Ligament Support



* Supports tendon recovery

* Promotes ligament health

* Helps maintain connective tissue integrity

* Supports mobility and flexibility



Tissue Repair



* Supports cellular regeneration

* Promotes healthy tissue remodeling

* May support wound healing

* Supports recovery from soft tissue injuries



Joint Health



* Supports joint function

* Helps maintain connective tissue health

* May promote cartilage support

* Supports overall musculoskeletal wellness



Anti-Inflammatory Support



* Supports a healthy inflammatory response

* May reduce localized tissue inflammation

* Promotes recovery after physical stress



Mechanism of Action



TB-500 Frag is being investigated for its ability to:



* Support cell migration involved in tissue repair

* Promote tissue remodeling

* Support connective tissue regeneration

* Help maintain normal healing processes

* Reduce oxidative and inflammatory stress during recovery



Suggested Administration



TB-500 Frag is generally administered by subcutaneous (SC) injection in research settings. There is no FDA-approved dosing regimen for general clinical use.



Storage



* Store lyophilized peptide refrigerated (2–8°C / 36–46°F)

* After reconstitution, refrigerate

* Protect from light

* Avoid repeated freeze-thaw cycles



Possible Side Effects



Human safety data remain limited. Potential side effects include:



* Mild injection site irritation

* Headache

* Temporary fatigue

* Nausea

* Dizziness (uncommon)



Research Areas



* Muscle recovery

* Tendon and ligament repair

* Soft tissue regeneration

* Sports medicine

* Wound healing

* Connective tissue health



Notes



* TB-500 Frag is an investigational peptide and is not FDA-approved for medical treatment in the United States.

* Research on the fragment is more limited than on full-length Thymosin Beta-4, and its long-term safety and effectiveness have not been established.

* Current evidence comes primarily from laboratory and preclinical studies, and additional human clinical research is needed to better define its therapeutic potential.